- Home
- OBT vs EVMN Comparison
OBT vs EVMN Comparison
Compare OBT & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBT | EVMN |
|---|---|---|
| Founded | 1892 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 457.5M | 475.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | OBT | EVMN |
|---|---|---|
| Price | $37.39 | $11.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $36.00 | ★ $43.88 |
| AVG Volume (30 Days) | 89.9K | ★ 1.4M |
| Earning Date | 04-28-2026 | 06-11-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 34.82 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.27 | N/A |
| Revenue Next Year | $7.99 | N/A |
| P/E Ratio | $43.99 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.25 | $11.15 |
| 52 Week High | $40.10 | $33.20 |
Technical Indicators
Market Signals| Indicator | OBT | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 33.16 |
| Support Level | $35.60 | N/A |
| Resistance Level | $38.26 | $21.21 |
| Average True Range (ATR) | 1.19 | 1.05 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 38.45 | 24.32 |
Price Performance
Historical ComparisonAbout OBT Orange County Bancorp Inc.
Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.